Institutional investors purchased a net $234.3 thousand shares of GHDX during the quarter ended March 2016 and now own 91.41% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAKER BROS. ADVISORS LP Bought 277.6 Thousand shares of Genomic Health Inc
AMERICAN CENTURY INVESTMENT MANA... Bought 28.4 Thousand shares of Genomic Health Inc
NORDEA INVESTMENT MANAGEMENT AB ... Bought 24.1 Thousand shares of Genomic Health Inc